Mexico is already seeing black-market or fake versions of Molnupiravir circulating for sale, just one week after authorities approved the drug to treat those at risk of severe COVID-19.
The real medication is produced by the U.S. pharmaceutical company Merck.
But Mexico’s health regulatory agency found versions labeled Molnupiravir for sale from an array of companies like “Merit,” “Molaz” and “Azista.”
The agency said on Friday, January 14th, that it had no record of any permits for import or sales of those companies’ drugs and considered them a health risk.
Mexico’s government approved Molnupiravir from Merck for use last week.
With information from INFOBAE
